Vorasidenib

About

Therapy type: Targeted therapy

Therapy strategy: IDH1/2 inhibition

Mappings

NCI Thesaurus: Vorasidenib (ncit:C152914)

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) IDH1 p.R132C Astrocytoma Vorasidenib
Sensitivity (+) IDH1 p.R132G Astrocytoma Vorasidenib
Sensitivity (+) IDH1 p.R132H Astrocytoma Vorasidenib
Sensitivity (+) IDH1 p.R132L Astrocytoma Vorasidenib
Sensitivity (+) IDH1 p.R132S Astrocytoma Vorasidenib
Sensitivity (+) IDH2 p.R172K Astrocytoma Vorasidenib
Sensitivity (+) IDH2 p.R172M Astrocytoma Vorasidenib
Sensitivity (+) IDH2 p.R172G Astrocytoma Vorasidenib
Sensitivity (+) IDH2 p.R172S Astrocytoma Vorasidenib
Sensitivity (+) IDH2 p.R172W Astrocytoma Vorasidenib
Sensitivity (+) IDH1 p.R132C Oligodendroglioma Vorasidenib
Sensitivity (+) IDH1 p.R132G Oligodendroglioma Vorasidenib
Sensitivity (+) IDH1 p.R132H Oligodendroglioma Vorasidenib
Sensitivity (+) IDH1 p.R132L Oligodendroglioma Vorasidenib
Sensitivity (+) IDH1 p.R132S Oligodendroglioma Vorasidenib
Sensitivity (+) IDH2 p.R172K Oligodendroglioma Vorasidenib
Sensitivity (+) IDH2 p.R172M Oligodendroglioma Vorasidenib
Sensitivity (+) IDH2 p.R172G Oligodendroglioma Vorasidenib
Sensitivity (+) IDH2 p.R172S Oligodendroglioma Vorasidenib
Sensitivity (+) IDH2 p.R172W Oligodendroglioma Vorasidenib